Copyright
©2014 Baishideng Publishing Group Co.
World J Crit Care Med. Feb 4, 2014; 3(1): 15-23
Published online Feb 4, 2014. doi: 10.5492/wjccm.v3.i1.15
Published online Feb 4, 2014. doi: 10.5492/wjccm.v3.i1.15
Table 4 Management of biologic agents
Agent | Pediatric dosing | Notes |
Inhalational anthrax | Ciprofloxacin 10-15 mg/kg iv q 12 h (max 400 mg) or doxycycline 2.2 mg/kg iv q 12 h (max 100 mg) plus clindamycin 10-15 mg/kg q 8 plus penicillin G 400-600 k U/kg per day iv divided q 4 h prophylaxis for exposed contacts ciprofloxacin 15 mg/kg po q 12 h or doxycycline 2.2 mg/kg po q 12 h | Switch to oral therapy when patient shows signs of improvement At least one agent should have good CNS penetration Prophylaxis is for a 60 d course Amoxicillin or levofloxacin are second line |
Plague | Gentamycin 2.5 mg/kg iv q 8 h or streptomycin 15 mg/kg im q 12 h (max 2 mg/d) or doxycycline 2.2 mg/kg iv q 12 h (max 200 mg/d) or ciprofloxacin 15 mg/kg iv q 12 h prophylaxis for exposed contacts trimethoprim/sulfa 4 mg/kg po q 12 h | Chloramphenical or Levofloxacin can also be used Prophylaxis should be continued for 5-7 d |
Tularemia | Same as therapy for plague | |
Botulism | Infants < 1 yr human-derived botulinum immunoglobulin children > 1 yr equine serum botulism antitoxin | In United States call 1-800-222-1222 or 770-488-7100 Outside United States contact local health agencies |
- Citation: Hamele M, Poss WB, Sweney J. Disaster preparedness, pediatric considerations in primary blast injury, chemical, and biological terrorism. World J Crit Care Med 2014; 3(1): 15-23
- URL: https://www.wjgnet.com/2220-3141/full/v3/i1/15.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v3.i1.15